Edition:
United Kingdom

Melinta Therapeutics, Inc. (MLNT.OQ)

MLNT.OQ on NASDAQ Stock Exchange Global Select Market

15.30USD
7:15pm GMT
Change (% chg)

$-0.30 (-1.92%)
Prev Close
$15.60
Open
$15.50
Day's High
$15.95
Day's Low
$15.15
Volume
31,709
Avg. Vol
33,236
52-wk High
$37.00
52-wk Low
$10.50

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -0.72 December 14 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 0 0 0
(2) OUTPERFORM 0 0 0 0
(3) HOLD 4 6 6 7
(4) UNDERPERFORM 0 1 1 1
(5) SELL 0 0 1 1
No Opinion 0 0 0 0
Mean Rating 2.60 3.14 3.38 3.33

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 2 2.83 4.57 1.10 8.87
Quarter Ending Mar-18 2 6.45 11.89 1.00 6.30
Year Ending Dec-17 3 9.84 12.02 8.50 21.04
Year Ending Dec-18 3 70.63 93.69 55.20 60.99
Earnings (per share)
Quarter Ending Dec-17 3 -0.72 -0.55 -0.96 -3.09
Quarter Ending Mar-18 2 -3.91 -1.01 -6.82 -1.60
Year Ending Dec-17 2 -4.99 -4.39 -5.60 -12.78
Year Ending Dec-18 4 -4.97 -3.14 -7.54 -10.60

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 2.22 1.72 0.51 22.80
Quarter Ending Jun-17 3.45 0.86 2.59 75.07
Quarter Ending Mar-17 4.82 4.87 0.05 1.02
Quarter Ending Dec-16 7.08 7.95 0.86 12.19
Quarter Ending Sep-16 3.90 3.97 0.08 1.95
Earnings (per share)
Quarter Ending Sep-17 -0.78 -1.00 0.22 -27.67
Quarter Ending Jun-17 -1.59 -1.15 0.44 -27.67
Quarter Ending Mar-17 -2.61 -1.85 0.76 -29.22
Quarter Ending Dec-16 -2.85 -3.00 0.15 -5.12
Quarter Ending Sep-16 -3.22 -3.10 0.12 -3.63

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 2.83 2.83 3.53 2.53 8.87
Quarter Ending Mar-18 6.45 6.45 2.54 0.00 6.30
Year Ending Dec-17 9.84 9.84 11.24 11.29 21.04
Year Ending Dec-18 70.63 70.63 8.03 7.30 60.99
Earnings (per share)
Quarter Ending Dec-17 -0.72 -0.72 -0.60 -0.74 -3.09
Quarter Ending Mar-18 -3.91 -3.91 -0.75 -1.02 -1.60
Year Ending Dec-17 -4.99 -4.99 -4.95 -5.08 -12.78
Year Ending Dec-18 -4.97 -4.97 -4.18 -3.84 -10.60

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 1
Quarter Ending Mar-18 0 0 1 0
Year Ending Dec-17 0 0 0 1
Year Ending Dec-18 0 0 1 0
Earnings
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 1
Year Ending Dec-18 0 0 0 1